On July 2, 2024, Calidi Biotherapeutics, Inc. has closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.151 USD | -6.85% |
|
-20.95% | -89.40% |
Jul. 05 | Calidi Biotherapeutics to Implement 1-For-10 Reverse Stock Split | MT |
Jul. 02 | Calidi Biotherapeutics, Inc. announced that it has received $0.6 million in funding | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-89.40% | 10.41M | |
+18.29% | 124B | |
+18.75% | 114B | |
+20.96% | 25.83B | |
-24.02% | 19.42B | |
-18.21% | 16.2B | |
-20.10% | 15.31B | |
+56.83% | 14.32B | |
+5.84% | 14.31B | |
-49.33% | 14.19B |
- Stock Market
- Equities
- CLDI Stock
- News Calidi Biotherapeutics, Inc.
- Calidi Biotherapeutics, Inc. announced that it has received $0.6 million in funding